FDA/CDC Retracted Emergency Use Authorization for PCR Testing For Testing That Can Differentiate Between SARS-CoV-2 & Influenza Viruses
What Experts and the inventor of the PCR test have always said – “The PCR test is not meant to detect if someone is sick or not”. Cases were nothing but propaganda.
The FDA notified the CDC that it is withdrawing their Emergency Use Authorization for PCR testing as of Dec 31 2021. The CDC is now notifying its laboratories to switch to alternate testing. One that can actually differentiate between Influenza Viruses and COVID.
CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel, the assay first introduced in February 2020 for detection of SARS-CoV-2 only. In preparation for this change, CDC recommends clinical laboratories and testing sites that have been using the CDC 2019-nCoV RT-PCR assay select and begin their transition to another FDA-authorized COVID-19 test.
CDC encourages laboratories to consider adoption of a multiplexed method that can facilitate detection and differentiation of SARS-CoV-2 and influenza viruses.
Imagine how many people actually believe Influenza suddenly disappeared because everyone wore masks.
The aftermath is going to be interesting.
READ IT HERE: https://www.cdc.gov/…/07-21-2021-lab-alert-Changes_CDC…
Suggested Articles
PCR Testing – Here’s How It Works And Why It Has Inflated Numbers
Kary Mullis, the Inventor of the PCR Test, on PCR and Anthony Fauci
Court Rules On PCR Tests
Not A Single Case Of Seasonal Flu This Season
